
| Trade Date | Filed | Owner | Role | Type | Shares | Price | Value | Owned After | ||
|---|---|---|---|---|---|---|---|---|---|---|
| 2026-05-21 | 2026-05-26 | Errico Thomas J. | Director | Purchase | 9,992 | $5.99 | $60K | 360.1K | View ↗ | |
| 2026-05-22 | 2026-05-22 | Lev Joshua S. | CFO and Interim President | Sale | 3,000 | $6.50 | $20K | 91.6K | View ↗ | |
| 2026-04-10 | 2026-04-14 | Goldberger Daniel S | Former Officer and Director | Sale | 16.1K | $6.02 | $97K | 291.5K | View ↗ | |
| 2025-12-04 | 2025-12-05 | Lev Joshua S. | Chief Financial Officer | Sale | 2,500 | $5.05 | $13K | 21.7K | View ↗ | |
| 2025-11-12 | 2025-11-14 | Lev Joshua S. | Chief Financial Officer | Sale | 2,166 | $6.18 | $13K | 23.7K | View ↗ |
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Net sales | $32.0M+27.2% | $25.2M+57.1% | $16.0M+86.6% | $8.6M+57.6% | $5.5M |
| Cost of goods sold | $4.2M+12.1% | $3.8M+35.0% | $2.8M+73.5% | $1.6M+16.7% | $1.4M |
| Gross profit | $27.8M+29.9% | $21.4M+61.8% | $13.2M+89.6% | $7.0M+71.6% | $4.1M |
| Research and development | $2.7M+15.9% | $2.4M-55.6% | $5.3M-3.6% | $5.5M+117.7% | $2.5M |
| Selling, general and administrative | $38.2M+22.5% | $31.2M+14.8% | $27.2M+11.7% | $24.3M+12.8% | $21.6M |
| Total operating expenses | $40.9M+22.0% | $33.6M+3.3% | $32.5M+8.9% | $29.9M+23.8% | $24.1M |
| Loss from operations | -$13.2M-8.1% | -$12.2M+36.9% | -$19.3M+15.8% | -$22.9M-14.1% | -$20.0M |
| Interest and other income | -$298K+47.9% | -$572K-32.1% | -$433K-50.9% | -$287K-2509.1% | -$11K |
| Interest expense | $590K+51.7% | $389K | — | — | — |
| Other expense | $518K | — | $184K+2966.7% | $6K-25.0% | $8K |
| Total other expense (income) | $810K+542.6% | -$183K | — | — | — |
| Loss before income taxes | -$14.0M-16.6% | -$12.0M+37.0% | -$19.0M+15.8% | -$22.6M-25.0% | -$18.1M |
| (Provision) benefit from income taxes | -$3K-103.2% | $93K-50.0% | $186K-56.8% | $431K-49.4% | $851K |
| Net loss | -$14.0M-17.5% | -$11.9M+36.9% | -$18.8M+15.0% | -$22.2M-28.7% | -$17.2M |
| Net loss per share of common stock - Basic | -$2K-3.8% | -$2K+53.5% | -$3K+27.1% | -$5K-7.6% | -$4K |
| Net loss per share of common stock - Diluted | -$2K-3.8% | -$2K+53.5% | -$3K+27.1% | -$5K-7.6% | -$4K |
| Weighted average common shares outstanding - Basic | $8.5M+13.4% | $7.5M+35.7% | $5.5M+16.6% | $4.7M+19.9% | $3.9M |
| Weighted average common shares outstanding - Diluted | $8.5M+13.4% | $7.5M+35.7% | $5.5M+16.6% | $4.7M+19.9% | $3.9M |
Source: SEC EDGAR XBRL. % change vs prior period shown where available.
electroCore Touts 30% Growth Outlook, VA Opportunity at LD Micro Conference
electroCore Announces Publication in JAMA Highlighting the Benefits of Adding Quell Electrical Nerve Stimulation to Outpatient Physical Therapy in Fibromyalgia
electroCore to Present at the LD Micro Invitational XVI Conference on May 18, 2026
electroCore (ECOR) Q1 2026 Earnings Transcript